ANI PHARMACEUTICALS, INC Operating Loss Carryforwards
ANI PHARMACEUTICALS, INC (ANIP) had Operating Loss Carryforwards of $10.50 million as of 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2021-03-11
- 2020-12-31: Operating Loss Carryforwards $10.50M.
- 2019-12-31: Operating Loss Carryforwards $11.30M.
- 2018-12-31: Operating Loss Carryforwards $12.10M.
- 2017-12-31: Operating Loss Carryforwards $12.90M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2020-12-31 | $10.50M 10-K · filed 2021-03-11 |
| 2019-12-31 | $11.30M 10-K · filed 2020-02-27 |
| 2018-12-31 | $12.10M 10-K · filed 2019-02-27 |
| 2017-12-31 | $12.90M 10-K · filed 2018-02-27 |
| 2016-12-31 | $13.70M 10-K · filed 2017-03-02 |
| 2015-12-31 | $21.70M 10-K · filed 2016-02-23 |
| 2014-12-31 | $32.90M 10-K · filed 2015-02-23 |
| 2013-12-31 | $235.30M 10-K · filed 2014-02-28 |
| 2012-12-31 | $192.73M 10-K · filed 2013-02-28 |
| 2011-12-31 | $169.46M 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |